SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013272
Filing Date
2022-08-11
Accepted
2022-08-11 16:06:18
Documents
80
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eqrx-20220630x10q.htm   iXBRL 10-Q 1915111
2 EX-31.1 eqrx-20220630xex31d1.htm EX-31.1 18750
3 EX-31.2 eqrx-20220630xex31d2.htm EX-31.2 18084
4 EX-32.1 eqrx-20220630xex32d1.htm EX-32.1 13725
5 GRAPHIC eqrx-20220630x10q002.jpg GRAPHIC 85388
  Complete submission text file 0001558370-22-013272.txt   8482945

Data Files

Seq Description Document Type Size
6 EX-101.SCH eqrx-20220630.xsd EX-101.SCH 54415
7 EX-101.CAL eqrx-20220630_cal.xml EX-101.CAL 44081
8 EX-101.DEF eqrx-20220630_def.xml EX-101.DEF 242862
9 EX-101.LAB eqrx-20220630_lab.xml EX-101.LAB 484107
10 EX-101.PRE eqrx-20220630_pre.xml EX-101.PRE 407361
74 EXTRACTED XBRL INSTANCE DOCUMENT eqrx-20220630x10q_htm.xml XML 1571946
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40312 | Film No.: 221155683
SIC: 2834 Pharmaceutical Preparations